Cookies & Privacy

We use essential cookies to make our site work. With your permission, we’ll also use analytics and marketing cookies to improve your experience. You can change your choice anytime.

See our Privacy Policy for details.

Manage preferences
Cookie preferences
Back to Industry News
Medtech

Nosa Expands European Reach: Enters Norwegian Pharmacy Market

Summary generated with AI, editor-reviewed
Heartspace News Desk
Source: Medtech Magazine
TL;DR

Nosa, a Swedish medtech company, is partnering with Apotera to introduce its nasal health products to the Norwegian pharmacy market. Four products will be launched: Nozoil, Odor Control, Microbial Control, and Smell Training, marking an expansion for Nosa in its European growth strategy.

Key takeaways

  • Swedish medtech company Nosa, specializing in nasal health products, is expanding into the Norwegian pharmacy market through a strategic partnership with Apotera, a leading Norwegian online pharmacy
  • The launch will introduce four key Nosa products to Norwegian consumers: Nozoil for dry nasal passages; Odor Control for managing unwanted smells; Microbial Control to reduce exposure to airborne viruses and bacteria; and Smell Training for individuals recovering their sense of smell
  • This expansion into Norway marks a significant step in Nosa's ongoing European growth strategy
Swedish medtech company Nosa, specializing in nasal health products, is expanding into the Norwegian pharmacy market through a strategic partnership with Apotera, a leading Norwegian online pharmacy. The launch will introduce four key Nosa products to Norwegian consumers: Nozoil for dry nasal passages; Odor Control for managing unwanted smells; Microbial Control to reduce exposure to airborne viruses and bacteria; and Smell Training for individuals recovering their sense of smell. This expansion into Norway marks a significant step in Nosa's ongoing European growth strategy.

Related Topics

medtechNosanasal healthpharmacyNorwayEuropean expansion

Share Your Thoughts

(0 comments)

Be the first to share your thoughts on this article!

Stay Updated

Create alertsRead original